Janne J.
- Country
- Denmark
- Department
- Department of Infectious Diseases
Research Overview
Data & Insights
Has run more than one trial at 1 of 92 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in treating hormone receptor-positive, HER2-negative advanced breast cancer, exploring innovative therapeutic approaches for patients who have progressed after initial treatments.
- Endocrine Therapy Resistance
- Advanced Breast Cancer Management
- Hormone Receptor Positive Disease
The investigator focuses on developing treatment strategies for patients with advanced breast cancer, particularly evaluating combination therapies involving targeted agents and hormonal treatments.
Therapeutic Innovation
Expertise centers on investigating novel therapeutic combinations, specifically the integration of PI3K inhibitors with endocrine therapy in advanced breast cancer treatment.
- Targeted Therapy Development
- Treatment Sequencing
- Resistance Mechanisms
The research encompasses evaluating treatment efficacy in patients who have received prior therapy with CDK4/6 inhibitors and aromatase inhibitors.
Clinical Outcomes
The investigator's work centers on evaluating progression-free survival in advanced breast cancer patients through innovative treatment combinations.
- Treatment Response Assessment
- Disease Progression Monitoring
- Clinical Efficacy Evaluation
Research efforts focus on determining the effectiveness of combination therapies in improving outcomes for patients with advanced hormone receptor-positive breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.